Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT00099658 Active, not recruiting - HIV Infections Clinical Trials

Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected Children

Start date: April 2005
Phase: N/A
Study type: Interventional

Infection by Streptococcal pneumoniae is a common invasive bacterial infection in HIV infected children. The purpose of this study is to determine the safety of and immune response to a pneumococcal polysaccharide-protein conjugate vaccine (PncCV) in HIV infected and uninfected children. The study will also determine the safety of and immune response to Haemophilus influenzae vaccine (HibCV) in these children. Recruitment for this study will occur at two hospitals in South Africa, and all HIV infected infants participating in this study must also be coenrolled in the CIPRA SA-Project 2 study.

NCT ID: NCT00097799 Approved for marketing - HIV Infections Clinical Trials

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Start date: December 2004
Phase: N/A
Study type: Expanded Access

This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.

NCT ID: NCT00097006 Completed - HIV Infections Clinical Trials

Retrovirus Epidemiology Donor Study-II (REDS-II)

Start date: September 2004
Phase: N/A
Study type: Observational

To conduct epidemiological, laboratory, and survey research on volunteer blood donors within the United States to ensure the safety and availability of the United States' blood supply.

NCT ID: NCT00093054 Completed - Clinical trials for Urinary Tract Infections

Cranberry Juice for Treatment of Urinary Tract Infections

Start date: November 2004
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether daily consumption of cranberry juice lessens the symptoms and prevents the recurrence of urinary tract infections (UTIs). This study will also determine whether drinking cranberry juice for 6 months selects for less virulent bacteria in the rectal, vaginal, and urethral areas.

NCT ID: NCT00092170 Completed - Infections Clinical Trials

An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)

Start date: March 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effect of an approved medication for adults for an investigational use in pediatric patients 3 months to 17 years for the treatment of complicated intra-abdominal infections or acute pelvic infections.

NCT ID: NCT00091819 Completed - Clinical trials for Staphylococcal Skin Infection

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

ATLAS1
Start date: January 2005
Phase: Phase 3
Study type: Interventional

Study 0017 compares the safety and effectiveness of an investigational drug, telavancin, and an approved drug, vancomycin, for the treatment of complicated skin and skin structure infections.

NCT ID: NCT00091728 Terminated - Chlamydia Infection Clinical Trials

Hormonal Contraception and Risk of Chlamydia and Gonorrhea

Start date: September 1997
Phase: Phase 4
Study type: Observational

There are biological reasons to suspect that hormones may affect the risk of a woman becoming infected with a sexually transmitted disease. The evidence on this issue to date is mixed and previous studies have methodologic flaws making it difficult to draw conclusions about the results. This study compares the risk of developing either Chlamydial or Gonorrheal infection among three groups of women: those using combined oral contraceptives (birth control pills); those using the injectable hormone (brand name Depo Provera); and those women using non-hormonal contraceptive methods.

NCT ID: NCT00089583 Completed - Clinical trials for Infection, Human Immunodeficiency Virus I

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

Start date: July 2004
Phase: Phase 2
Study type: Interventional

This is a 48-week study to collect information on the safety and activity of an investigational medicine in patients, ages 2 to 18 years old, with HIV infection .

NCT ID: NCT00087490 Completed - Clinical trials for Methicillin Resistant Staphylococcus Aureus (MRSA)

Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

Start date: October 2004
Phase: Phase 4
Study type: Interventional

To determine if linezolid is superior to vancomycin in the treatment of complicated skin and soft tissue infections due to MRSA in adult subjects

NCT ID: NCT00086372 Completed - HIV Infections Clinical Trials

Long-term Follow-up of HIV Infected Patients Identified During Early Infection

Start date: July 2003
Phase: N/A
Study type: Observational

This is a long-term follow-up study of people who are identified during acute or recent HIV infection and are being followed at clinical research sites associated with the Acute HIV Infection and Early Disease Research Program (AIEDRP).